» Articles » PMID: 28154098

Stroke Risk Factors, Genetics, and Prevention

Overview
Journal Circ Res
Date 2017 Feb 4
PMID 28154098
Citations 607
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is a heterogeneous syndrome, and determining risk factors and treatment depends on the specific pathogenesis of stroke. Risk factors for stroke can be categorized as modifiable and nonmodifiable. Age, sex, and race/ethnicity are nonmodifiable risk factors for both ischemic and hemorrhagic stroke, while hypertension, smoking, diet, and physical inactivity are among some of the more commonly reported modifiable risk factors. More recently described risk factors and triggers of stroke include inflammatory disorders, infection, pollution, and cardiac atrial disorders independent of atrial fibrillation. Single-gene disorders may cause rare, hereditary disorders for which stroke is a primary manifestation. Recent research also suggests that common and rare genetic polymorphisms can influence risk of more common causes of stroke, due to both other risk factors and specific stroke mechanisms, such as atrial fibrillation. Genetic factors, particularly those with environmental interactions, may be more modifiable than previously recognized. Stroke prevention has generally focused on modifiable risk factors. Lifestyle and behavioral modification, such as dietary changes or smoking cessation, not only reduces stroke risk, but also reduces the risk of other cardiovascular diseases. Other prevention strategies include identifying and treating medical conditions, such as hypertension and diabetes, that increase stroke risk. Recent research into risk factors and genetics of stroke has not only identified those at risk for stroke but also identified ways to target at-risk populations for stroke prevention.

Citing Articles

Targeted Metabolomics in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Ament Z, Kijpaisalratana N, Bhave V, Couch C, Garcia Guarniz A, Patki A Sci Data. 2025; 12(1):395.

PMID: 40050322 PMC: 11885657. DOI: 10.1038/s41597-025-04746-x.


Clinical and Therapeutic Characteristics of Stroke and Their Implications on Outcomes: A Multi-center Study in Panama.

Villarreal E, Wolfschoon H, Salehji A, Patino K, Cardoze D, Billingslea V Cureus. 2025; 17(2):e78438.

PMID: 40046353 PMC: 11882105. DOI: 10.7759/cureus.78438.


The association of upper limb sensorimotor capacity, everyday inpatient behavior, and the effects of neurorehabilitation in persons with multiple sclerosis and stroke: a mixed-design study.

Gulde P, Vojta H, Schmidle S, Rieckmann P, Hermsdorfer J J Neuroeng Rehabil. 2025; 22(1):49.

PMID: 40045323 PMC: 11884105. DOI: 10.1186/s12984-025-01586-z.


Psychological Factors and Post-Traumatic Stress Disorder (PTSD) Risk in Stroke Survivors: A Cross-Sectional Study.

Nguyen N, Le S, Bui H, Hoang V, Do C Health Psychol Res. 2025; 13:129914.

PMID: 40041686 PMC: 11879064. DOI: 10.52965/001c.129914.


Artificial intelligence in stroke risk assessment and management via retinal imaging.

Khalafi P, Morsali S, Hamidi S, Ashayeri H, Sobhi N, Pedrammehr S Front Comput Neurosci. 2025; 19:1490603.

PMID: 40034651 PMC: 11872910. DOI: 10.3389/fncom.2025.1490603.


References
1.
Annes J, Munger J, Rifkin D . Making sense of latent TGFbeta activation. J Cell Sci. 2002; 116(Pt 2):217-24. DOI: 10.1242/jcs.00229. View

2.
Goldstein L, Amarenco P, Szarek M, Callahan 3rd A, Hennerici M, Sillesen H . Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2007; 70(24 Pt 2):2364-70. DOI: 10.1212/01.wnl.0000296277.63350.77. View

3.
Grundy S, Pasternak R, Greenland P, Smith Jr S, Fuster V . AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 1999; 34(4):1348-59. DOI: 10.1016/s0735-1097(99)00387-3. View

4.
Perry I, Beevers D . Salt intake and stroke: a possible direct effect. J Hum Hypertens. 1992; 6(1):23-5. View

5.
Elkind M, Luna J, Moon Y, Boden-Albala B, Liu K, Spitalnik S . Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke. 2010; 41(3):e117-22. PMC: 2830875. DOI: 10.1161/STROKEAHA.109.571299. View